Big Pharma overcharged NHS millions for anti-epilepsy drug – competition watchdog

‘US pharma giant Pfizer and Hertfordshire-based drug company Flynn Pharma abused their market dominance by charging “excessive and unfair prices” for an anti-epilepsy drug, Britain’s competition watchdog has said.

Following a comprehensive investigation, the Competition and Markets Authority (CMA) released a scathing statement on Thursday suggesting the two pharma firms may have breached UK and EU competition law.

The alleged legal breach is estimated to have cost the National Health Service (NHS) dearly, with its spending on the drug increasing 22-fold in three years.’

Read more: Big Pharma overcharged NHS millions for anti-epilepsy drug – competition watchdog

The post Big Pharma overcharged NHS millions for anti-epilepsy drug – competition watchdog appeared first on David Icke.